EW vs PCB · P/E 47, rev $1.39B vs P/E 11, rev $2.8M
Edwards Lifesciences Corp (EW) versus PCB Bancorp (PCB) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
PCB Bancorp (PCB) is a banks - regional company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported PCB revenue for 2024-12-31 was $2.8M. Net income was $25.8M. Revenue was up 4.7% from 2023-12-31 to 2024-12-31. PCB currently screens at market cap $308.8M and trailing P/E 10.8.
EW currently screens at market cap $49.91B and trailing P/E 46.9. PCB currently screens at market cap $308.8M and trailing P/E 10.8.
Not investment advice. Open the EW and PCB stock pages for the full models.
Not investment advice.